Biopharma startup

IVIM Technology

IVIM Technology offers live cell intravital imaging, repetitive intravital imaging, drug efficacy, and delivery monitoring solutions.

Funding reportedLast round: Series C

BiopharmaDaejeon

What company datasets say IVIM Technology raised

Funding, as reported

Reported in all15Bin the source's currency
Rounds2
Last roundSeries C
Last round dateApr 2022
Investors listed7

On 2 portfolio pages

Investors who name them

Each firm lists IVIM Technology on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biopharma in the same market

Startups like it

Is this your company?

Add your raise, your deck and your story, and put IVIM Technology in front of investors. Or tell us what we have wrong.